# POMALIDOMIDE
> **ANDA210275** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2022-01-26
## Drug
- **FDA Application Number:** ANDA210275
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POMALIDOMIDE
- **Generic name:** Pomalidomide
- **Active ingredients:** POMALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2022-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210275)
---
*AI Analytics · CC0 1.0*